logo
Select company
Select metric
$ -8.45MEarning Before Interest & Taxes (EBIT)
VS
Market
32
Sector
67
Industry
82
History
74
$ 0.38Close
$ 0.23 - $ 1.23 52-Week Range
Ticker Information

Ticker

ADIL

Company Name

ADIAL PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ADIAL PHARMACEUTICALS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ADIL - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -8.45M
3/31/2025$ -8.95M
12/31/2024$ -13.2M
9/30/2024$ -13.05M
6/30/2024$ -12.24M
3/31/2024$ -8.69M
12/31/2023$ -5.12M
9/30/2023$ -6.07M
6/30/2023$ -7.79M
3/31/2023$ -12.73M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ADIAL PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBIT stands at $ -9.48M.
  • Over the past 5 years, ADIAL PHARMACEUTICALS INC's average EBIT has been $ -12.29M.
  • The median EBIT for ADIAL PHARMACEUTICALS INC during this period was $ -12.73M
  • ADIAL PHARMACEUTICALS INC reached its highest EBIT over the past 5 years at $ -5.12M.
  • The lowest EBIT recorded by ADIAL PHARMACEUTICALS INC in the same timeframe $ -19.52M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

ADIL - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -19.52M

Minimum

Dec 31, 2021

$ -5.12M

Maximum

Dec 31, 2023

$ -12.29M

Average

$ -12.73M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.81M with a standard deviation of $ 130.86M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 443M
average$ 28.81M
median$ 1.05M
std$ 130.86M